Hemrajani Rekha

CIK 00017712138 companiesROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001771213

Recent Transactions

34 trades

Award
MAXCYTE, INC.$MXCT
Common Stock
2026-06-17+30,421→ 70,314 total
Award
MAXCYTE, INC.$MXCT
Stock Option (right to buy)
2026-06-17+49,579→ 49,579 total
Award
BioAge Labs, Inc.$BIOA
Stock Option (Right to Buy)
2026-06-10+22,000→ 22,000 total
Award
LB PHARMACEUTICALS INC$LBRX
Stock Option (Right to Buy)
2026-06-03+10,000→ 10,000 total
Award
ALX ONCOLOGY HOLDINGS INC$ALXO
Stock option (right to buy)
2026-01-20+40,400→ 40,400 total
Award
LB PHARMACEUTICALS INC$LBRX
Stock Option (Right to Buy)
2025-09-10+22,449→ 22,449 total
Sale
MAXCYTE, INC.$MXCT
Common Stock
2025-06-25$2.09/sh−10,684→ 39,893 total
Award
MAXCYTE, INC.$MXCT
Stock Option (right to buy)
2025-06-18+50,790→ 50,790 total
Award
MAXCYTE, INC.$MXCT
Common Stock
2025-06-18+29,210→ 50,577 total
Award
BioAge Labs, Inc.$BIOA
Stock Option (Right to Buy)
2025-06-05+22,000→ 22,000 total
Award
ALX ONCOLOGY HOLDINGS INC$ALXO
Stock Option (right to buy)
2025-01-21+40,400→ 40,400 total
Purchase
ALX ONCOLOGY HOLDINGS INC$ALXO
Common Stock
2024-12-02$1.55/sh+30,000→ 33,000 total
Purchase
BioAge Labs, Inc.$BIOA
Common Stock
2024-09-27$18.00/sh+3,000→ 3,000 total
Award
BioAge Labs, Inc.$BIOA
Stock Option (Right to Buy)
2024-09-25+15,000→ 15,000 total
Award
ALX ONCOLOGY HOLDINGS INC$ALXO
Stock Option (right to buy)
2024-06-13+20,200→ 20,200 total
Award
MAXCYTE, INC.$MXCT
Common Stock
2024-06-11+21,367→ 21,367 total
Award
MAXCYTE, INC.$MXCT
Stock Option (right to buy)
2024-06-11+40,701→ 40,701 total
Award
BioAge Labs, Inc.$BIOA
Stock Option (Right to Buy)
2024-04-17+28,497→ 28,497 total
Award
MAXCYTE, INC.$MXCT
Stock Option (right to buy)
2023-06-22+50,000→ 50,000 total
Award
ALX ONCOLOGY HOLDINGS INC$ALXO
Stock Option (right to buy)
2023-06-20+20,200→ 20,200 total
Award
MAXCYTE, INC.$MXCT
Stock Option (right to buy)
2023-03-20+40,000→ 40,000 total
Award
MAXCYTE, INC.$MXCT
Stock Option (right to buy)
2022-06-29+26,900→ 26,900 total
Award
ALX ONCOLOGY HOLDINGS INC$ALXO
Stock Option (right to buy)
2022-06-15+12,004→ 12,004 total
Award
MAXCYTE, INC.$MXCT
Stock Option (right to buy)
2021-08-09+10,000→ 10,000 total
Award
ALX ONCOLOGY HOLDINGS INC$ALXO
Stock Option (right to buy)
2021-06-11+12,004→ 12,004 total
Purchase
ALX ONCOLOGY HOLDINGS INC$ALXO
Common Stock
2020-07-21$19.00/sh+3,000→ 3,000 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2020-06-23+30,000→ 30,000 total
Disposition to Issuer
Aravive, Inc.
Common Stock
2020-04-08−42,750→ 14,250 total
Award
Aravive, Inc.
Common Stock
2020-01-09+57,000→ 57,000 total
Award
Aravive, Inc.
Stock Options
2020-01-09+143,000→ 143,000 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2019-08-15+33,750→ 45,000 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2019-07-31+11,250→ 11,250 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2019-05-01+70,000→ 70,000 total
Award
Arcus Biosciences, Inc.$RCUS
Stock Option (right to buy)
2019-03-25+400,000→ 400,000 total

Companies

Recent Filings

Address

C/O MAXCYTE, INC. 9713 KEY WEST AVENUE, SUITE 400

ROCKVILLE, MD, 20850

View on SEC.gov